Cooper KD - Search Results

1

Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study.

Ho VC, Griffiths CE, Ellis CN, Gupta AK, McCuaig CC, Nickoloff BJ, Cooper KD, Hamilton TA, Voorhees JJ. Ho VC, et al. Among authors: cooper kd. J Am Acad Dermatol. 1990 Jan;22(1):94-100. doi: 10.1016/0190-9622(90)70015-a. J Am Acad Dermatol. 1990. PMID: 2298969 Clinical Trial.

2

Skin-infiltrating lymphocytes in normal and disordered skin: activation signals and functional roles in psoriasis and mycosis fungoides-type cutaneous T cell lymphoma.

Cooper KD. Cooper KD. J Dermatol. 1992 Nov;19(11):731-7. doi: 10.1111/j.1346-8138.1992.tb03770.x. J Dermatol. 1992. PMID: 1293160

3

Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin.

Tavakkol A, Elder JT, Griffiths CE, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, Voorhees JJ. Tavakkol A, et al. Among authors: cooper kd. J Invest Dermatol. 1992 Sep;99(3):343-9. doi: 10.1111/1523-1747.ep12616668. J Invest Dermatol. 1992. PMID: 1324963 Free article.

4

T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.

Chang EY, Hammerberg C, Fisher G, Baadsgaard O, Ellis CN, Voorhees JJ, Cooper KD. Chang EY, et al. Among authors: cooper kd. Arch Dermatol. 1992 Nov;128(11):1479-85. Arch Dermatol. 1992. PMID: 1359841

5

UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion.

Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, LeVee G, Anderson T, Koren H. Cooper KD, et al. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8497-501. doi: 10.1073/pnas.89.18.8497. Proc Natl Acad Sci U S A. 1992. PMID: 1382291 Free PMC article.

6

Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

Hammerberg C, Arend WP, Fisher GJ, Chan LS, Berger AE, Haskill JS, Voorhees JJ, Cooper KD. Hammerberg C, et al. Among authors: cooper kd. J Clin Invest. 1992 Aug;90(2):571-83. doi: 10.1172/JCI115896. J Clin Invest. 1992. PMID: 1386612 Free PMC article.

7

Mycosis fungoides--type cutaneous T-cell lymphoma arising before 30 years of age. Immunophenotypic, immunogenotypic and clinicopathologic analysis of nine cases.

Burns MK, Ellis CN, Cooper KD. Burns MK, et al. Among authors: cooper kd. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):974-8. doi: 10.1016/0190-9622(92)70297-s. J Am Acad Dermatol. 1992. PMID: 1479104

8

Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor.

Kim NI, Cooper KD, Fisher GJ, Baadsgaard O, Voorhees JJ, Hammerberg C. Kim NI, et al. Among authors: cooper kd. Arch Dermatol Res. 1992;284(2):71-6. doi: 10.1007/BF00373372. Arch Dermatol Res. 1992. PMID: 1610215 Free article.

9

Langerhans cell sensitivity to in vitro versus in vivo loading with cyclosporine A.

Cooper KD, Baadsgaard O, Duell E, Fisher G, Ellis CN, Voorhees JJ. Cooper KD, et al. J Invest Dermatol. 1992 Feb;98(2):259-61. doi: 10.1111/1523-1747.ep12556095. J Invest Dermatol. 1992. PMID: 1732391 Free article. No abstract available.

10

Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.

Hansen ER, Baadsgaard O, Lisby S, Cooper KD, Thomsen K, Vejlsgaard GL. Hansen ER, et al. Among authors: cooper kd. J Invest Dermatol. 1990 Apr;94(4):485-91. doi: 10.1111/1523-1747.ep12874650. J Invest Dermatol. 1990. PMID: 1968933 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters